PXS Provexis plc

LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · provexis.com

0.9500GBp-1.04%Mkt Cap: 24.22M $P/E: —Today

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. It provides syrup and powder versions of Fruitflow, a tomato extract that re…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap24.22M USD

Enterprise Value22.93M USD

Revenue (TTM)1.37M USD

Gross Profit579.28K USD

Net Income (TTM)-492.09K USD

Revenue/Share0.0010 GBp

Last Price0.9500 GBp

Fiscal Year EndMar 2026

MR QuarterMar 2026

Employees2

CountryGB

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue16.68

P/S17.81

P/B—

EPS (TTM)0.00

EPS (Forward)—

52W Range

0.006261% of range1.550

52W High1.550 GBp

52W Low0.0062 GBp

Profitability

Gross Margin41.24%

Oper. Margin-22.42%

EBITDA Margin0.00%

Profit Margin-35.03%

ROE-34.89%

ROA-44.73%

Growth

Revenue Growth77.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-370.47K USD

CapEx (TTM)—

FCF Margin28.90%

FCF Yield1.64%

Net Debt-970.81K USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio1.79

Quick Ratio1.37

Book Value/Sh0.00 GBp

Cash/Share0.00 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBp

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateJun 23, 2005

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.2.35B

Float1.81B

Insiders20.84%

Institutions9.87%

Technical

SMA 501.065 (-10.8%)

SMA 2001.101 (-13.7%)

Beta0.65

S&P 52W Chg14.58%

Avg Vol (30d)668.63K

Avg Vol (10d)1.25M

Technical Indicators

RSI (14)44.0

MACD-0.0482

MACD Signal-0.0428

MACD Hist.-0.0054

BB Upper1.175 GBp

BB Middle1.008 GBp

BB Lower0.8403 GBp

BB Width33.18%

ATR (14)0.1821 GBp

Vol Ratio (20d)1.32x